Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olcegepant (BIBN 4096 BS) Dose-Ranging Study in Acute Migraine
NCT02198339Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 1999
- Primary completion
- Dec 1999
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of olcegepant in migraine, sponsored by Boehringer Ingelheim. Started Feb 1999; status: completed.
02
Drugs
olcegepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02198339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02198339.